It has been shown that the TGFβ-neutralising mAb 1D11 can markedly enhance the abscopal effects and overall treatment efficacy of combined radio- and immunotherapy in both mouse breast and colorectal cancer models [178]. Here, TGFB1 is linked to colorectal cancer.